Anticoagulant Sodium Citrate Solution

Safety Data Sheet

According to Regulation (EC) No. 1907/2006 (REACH) with its amendment Regulation (EU) 2015/830
Revision date: 29/10/2015 Date of issue: 29/10/2015 Version: 1.0

SECTION 1: Identification of the substance/mixture and of the company/undertaking

1.1. Product identifier
Product form : Mixture
Product Name : Anticoagulant Sodium Citrate Solution
1.2. Relevant identified uses of the substance or mixture and uses advised against
1.2.1. Relevant identified uses
Use of the substance/mixture : Blood coagulation prevention.
1.2.2. Uses advised against
No additional information available
1.3. Details of the supplier of the safety data sheet
Haemonetics Corporation
400 Wood Road
Braintree, MA 02184
1.4. Emergency telephone number
Emergency number : Contact the Environmental, Health & Safety Department – (781) 848-7100
SECTION 2: Hazards identification
2.1. Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP]
Not classified
Adverse physicochemical, human health and environmental effects
No additional information available
2.2. Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
No labelling applicable
2.3. Other hazards
Other hazards not contributing to the : Exposure may aggravate pre-existing eye, skin, or respiratory conditions.
classification
SECTION 3: Composition/information on ingredients
3.1. Substance
Not applicable
3.2. Mixture
Name Product identifier % Classification according to Regulation
(EC) No. 1272/2008 [CLP]
Water for injection (CAS No) 7732-18-5 96 Not classified
(EC no) 231-791-2
Trisodium citrate dihydrate (CAS No) 6132-04-3 4 Not classified
(EC no) 612-118-5
SECTION 4: First aid measures
4.1. Description of first aid measures
First-aid measures general : Never give anything by mouth to an unconscious person. If you feel unwell, seek
medical advice (show the label where possible).
First-aid measures after inhalation : When symptoms occur: go into open air and ventilate suspected area. Obtain
medical attention if breathing difficulty persists.
First-aid measures after skin contact : Remove contaminated clothing. Drench affected area with Water for injection for
at least 15 minutes. Obtain medical attention if irritation develops or persists.
First-aid measures after eye contact : Rinse cautiously with Water for injection for at least 15 minutes. Remove contact
lenses, if present and easy to do. Continue rinsing. Obtain medical attention.
First-aid measures after ingestion : Rinse mouth. Do NOT induce vomiting. Obtain medical attention.

29/10/2015 EN (English) 1/5

HAEMO:CL102969-IE(AA)
Anticoagulant Sodium Citrate Solution
Safety Data Sheet
According to Regulation (EC) No. 1907/2006 (REACH) with its amendment Regulation (EU) 2015/830

4.2. Most important symptoms and effects, both acute and delayed
Symptoms/injuries : Not expected to present a significant hazard under anticipated conditions of
normal use.
Symptoms/injuries after inhalation : Prolonged exposure may cause irritation.
Symptoms/injuries after skin contact : Prolonged exposure may cause skin irritation.
Symptoms/injuries after eye contact : May cause slight irritation to eyes.
Symptoms/injuries after ingestion : Ingestion may cause adverse effects.
4.3. Indication of any immediate medical attention and special treatment needed
If exposed or concerned, get medical advice and attention. If medical advice is needed, have product container or label at hand.
SECTION 5: Firefighting measures
5.1. Extinguishing media
Suitable extinguishing media : Water for injection spray, dry chemical, foam, carbon dioxide.
Unsuitable extinguishing media : Do not use a heavy Water for injection stream. Use of heavy stream of Water for
injection may spread fire.
5.2. Special hazards arising from the substance or mixture
Fire hazard : Not considered flammable but may burn at high temperatures.
Explosion hazard : Product is not explosive.
Reactivity : Hazardous reactions are not expected to occur under normal conditions.
5.3. Advice for firefighters
Precautionary measures fire : Exercise caution when fighting any chemical fire.
Firefighting instructions : Use Water for injection spray or fog for cooling exposed containers.
Protection during firefighting : Do not enter fire area without proper protective equipment, including respiratory
protection.
SECTION 6: Accidental release measures
6.1. Personal precautions, protective equipment and emergency procedures
General measures : Avoid prolonged contact with eyes, skin and clothing. Avoid breathing (vapor, mist,
spray).
6.1.1. For non-emergency personnel
Protective equipment : Use appropriate personal protection equipment (PPE).
Emergency procedures : Evacuate unnecessary personnel.
6.1.2. For emergency responders
Protective equipment : Equip cleanup crew with proper protection.
Emergency procedures : Ventilate area. Upon arrival at the scene, a first responder is expected to recognize
the presence of dangerous goods, protect oneself and the public, secure the area,
and call for the assistance of trained personnel as soon as conditions permit.
6.2. Environmental precautions
Prevent entry to sewers and public Water for injections.
6.3. Methods and material for containment and cleaning up
For containment : Contain any spills with dikes or absorbents to prevent migration and entry into
sewers or streams.
Methods for cleaning up : Clean up spills immediately and dispose of waste safely. Transfer spilled material
to a suitable container for disposal. Contact competent authorities after a spill.
6.4. Reference to other sections
See Heading 8. Exposure controls and personal protection. See Section 13, Disposal Considerations.
SECTION 7: Handling and storage
7.1. Precautions for safe handling
Precautions for safe handling : Wash hands and other exposed areas with mild soap and Water for injection before
eating, drinking or smoking and when leaving work. Avoid prolonged contact with
eyes, skin and clothing. Avoid breathing vapors, mist, spray.
Hygiene measures : Handle in accordance with good industrial hygiene and safety procedures.
7.2. Conditions for safe storage, including any incompatibilities
Technical measures : Comply with applicable regulations.
Storage conditions : Keep container closed when not in use. Store in a dry, cool place. Recommended
storage temperature: 25°C (77°F). Keep/Store away from direct sunlight, extremely
high or low temperatures and incompatible materials.
29/10/2015 EN (English) 2/5
HAEMO:CL102969-IE(AA)
Anticoagulant Sodium Citrate Solution
Safety Data Sheet
According to Regulation (EC) No. 1907/2006 (REACH) with its amendment Regulation (EU) 2015/830

Incompatible materials : Strong acids, strong bases, strong oxidizers. Water for injection reactive
substances.
7.3. Specific end use(s)
Blood coagulation prevention.
SECTION 8: Exposure controls/personal protection
8.1. Control parameters
No additional information available
8.2. Exposure controls
Appropriate engineering controls : Emergency eye wash fountains and safety showers should be available in the
immediate vicinity of any potential exposure. Ensure adequate ventilation,
especially in confined areas. Ensure all national/local regulations are observed.
Personal protective equipment : Gloves. Protective clothing. Protective goggles.

Materials for protective clothing : Chemically resistant materials and fabrics.

Hand protection : Wear protective gloves.
Eye protection : Chemical safety goggles.
Skin and body protection : Wear suitable protective clothing.
Respiratory protection : If exposure limits are exceeded or irritation is experienced, approved respiratory
protection should be worn. In case of inadequate ventilation, oxygen deficient
atmosphere, or where exposure levels are not known wear approved respiratory
protection.
Other information : When using, do not eat, drink or smoke.
SECTION 9: Physical and chemical properties
9.1. Information on basic physical and chemical properties
Physical state : Liquid
Colour : Clear
Odour : None
Odour threshold : No data available
pH : No data available
Evaporation rate : No data available
Melting point : No data available
Freezing point : No data available
Boiling point : No data available
Flash point : No data available
Auto-ignition temperature : No data available
Decomposition temperature : No data available
Flammability (solid, gas) : No data available
Vapour pressure : No data available
Relative vapour density at 20 °C : No data available
Solubility : Water for injection: Soluble
Partition coefficient: n-octanol/Water for injection : No data available
Viscosity : No data available
Explosive properties : No data available
Oxidising properties : No data available
Explosive limits : No data available
9.2. Other information
No additional information available
SECTION 10: Stability and reactivity
10.1. Reactivity
Hazardous reactions are not expected to occur under normal conditions.
29/10/2015 EN (English) 3/5
HAEMO:CL102969-IE(AA)
Anticoagulant Sodium Citrate Solution
Safety Data Sheet
According to Regulation (EC) No. 1907/2006 (REACH) with its amendment Regulation (EU) 2015/830

10.2. Chemical stability

Stable under recommended handling and storage conditions (see section 7).
10.3. Possibility of hazardous reactions
Hazardous polymerization will not occur.
10.4. Conditions to avoid
Direct sunlight, extremely high or low temperatures, and incompatible materials.
10.5. Incompatible materials
Strong acids, strong bases, strong oxidizers. Water for injection reactive substances.
10.6. Hazardous decomposition products
Upon thermal decomposition: Carbon oxides (CO, CO2).
SECTION 11: Toxicological information
11.1. Information on toxicological effects
Acute toxicity : Not classified
Skin corrosion/irritation : Not classified
Serious eye damage/irritation : Not classified
Respiratory or skin sensitisation : Not classified
Germ cell mutagenicity : Not classified
Carcinogenicity : Not classified
Reproductive toxicity : Not classified
Specific target organ toxicity (single exposure) : Not classified
Specific target organ toxicity (repeated exposure) : Not classified
Aspiration hazard : Not classified
Potential adverse human health effects and : Based on available data, the classification criteria are not met.
symptoms
SECTION 12: Ecological information
12.1. Toxicity
Ecology - general : Not classified.
12.2. Persistence and degradability
Anticoagulant Sodium Citrate Solution
Persistence and degradability Not established.
12.3. Bioaccumulative potential
Anticoagulant Sodium Citrate Solution
Bioaccumulative potential Not established.
12.4. Mobility in soil
No additional information available
12.5. Results of PBT and vPvB assessment
No additional information available
12.6. Other adverse effects
Other information : Avoid release to the environment.
SECTION 13: Disposal considerations
13.1. Waste treatment methods
Waste disposal recommendations : Dispose of contents/container in accordance with local, regional, national, and
international regulations.
Additional information : Container may remain hazardous when empty. Continue to observe all precautions.
Ecology - waste materials : Avoid release to the environment.
SECTION 14: Transport information
In accordance with ADR / RID / IMDG / IATA / ADN
14.1. UN number
Not regulated for transport
14.2. UN proper shipping name
Not applicable

29/10/2015 EN (English) 4/5

HAEMO:CL102969-IE(AA)
Anticoagulant Sodium Citrate Solution
Safety Data Sheet
According to Regulation (EC) No. 1907/2006 (REACH) with its amendment Regulation (EU) 2015/830

14.3. Transport hazard class(es)

Not applicable
14.4. Packing group
Not applicable
14.5. Environmental hazards
Other information : No supplementary information available.
14.6. Special precautions for user
14.6.1. Overland transport
No additional information available
14.6.2. Transport by sea
No additional information available
14.6.3. Air transport
No additional information available
14.7. Transport in bulk according to Annex II of MARPOL and the IBC Code
Not applicable
SECTION 15: Regulatory information
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture
15.1.1. EU-Regulations
Contains no REACH substances with Annex XVII restrictions
Contains no substance on the REACH candidate list
Contains no REACH Annex XIV substances
15.1.2. National regulations
No additional information available
15.2. Chemical safety assessment
No chemical safety assessment has been carried out
SECTION 16: Other information
Revision date : 29/10/2015
Data sources : According to Regulation (EC) No. 1907/2006 (REACH) with its amendment
Regulation (EU) 2015/830

EU GHS SDS

This information is based on our current knowledge and is intended to describe the product for the purposes of health, safety and
environmental requirements only. It should not therefore be construed as guaranteeing any specific property of the product.

29/10/2015 EN (English) 5/5

HAEMO:CL102969-IE(AA)